NDLI: Patient-identified early clinical warning signs of nodular melanoma: a qualitative study

Content Provider	Springer Nature : BioMed Central
Author	Coroiu, Adina Moran, Chelsea Davine, Jessica A. Brophy, Kyla Bergeron, Catherine Tsao, Hensin Körner, Annett Swetter, Susan M. Geller, Alan C.
Abstract	Background Nodular (NM) and superficial spreading melanoma (SSM) show different disease trajectories, with more rapid development in NM and fewer opportunities for early detection often resulting in worse outcomes. Our study described the patient-identified early signs of thin NM via comparisons to thin (≤ 2 mm) SSM and thick (> 2 mm) NM. Methods We conducted semi-structured interviews with NM and SSM patients and analyzed the data using thematic analysis. Results We enrolled 34 NM and 32 SSM patients. Melanoma early signs uniquely identified by patients with thin NM included white, blue or black coloration, “dot-like” size, fast changes in shape and color observed over 2 weeks, elevation and texture or “puffiness” over 6–12 months, and the sensation that the mole “did not feel right”. Early signs reported by both thin NM and thin SSM patients included round or oblong shape, “jagged” border, pink/red, brown/reddish or dark coloration, “elevated like a pimple” or “tiny bump”, fast color darkening, diameter growth, and border irregularity, and mole feeling “really itchy”. Conclusions We found evidence that early signs of NM can be self-identified, which has important implications for the earlier detection of this most aggressive type of melanoma by both health professionals and patients.
Related Links	https://bmccancer.biomedcentral.com/counter/pdf/10.1186/s12885-021-08072-4.pdf
Ending Page	12
Page Count	12
Starting Page	1
File Format	HTM / HTML
ISSN	14712407
DOI	10.1186/s12885-021-08072-4
Journal	BMC Cancer
Issue Number	1
Volume Number	21
Language	English
Publisher	BioMed Central
Publisher Date	2021-04-07
Access Restriction	Open
Subject Keyword	Cancer Research Oncology Surgical Oncology Health Promotion and Disease Prevention Biomedicine Medicine Public Health Nodular melanoma Superficial spreading melanoma Patient-identified early signs Semi-structured interviews Thematic analysis Medicine/Public Health
Content Type	Text
Resource Type	Article
Subject	Cancer Research Oncology Genetics
Journal Impact Factor	3.4/2023
5-Year Journal Impact Factor	3.8/2023

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Patient perspectives on molecular tumor profiling: “Why wouldn’t you?”

Facilitators and barriers to reducing chemotherapy for early-stage breast cancer: a qualitative analysis of interviews with patients and patient advocates

GNAQmutation in a patient with metastatic mucosal melanoma

Adjuvant immunotherapy recommendations for stage III melanoma: physician and nurse interviews

Silvestrol induces early autophagy and apoptosis in human melanoma cells

Oncological healthcare providers’ perspectives on appropriate melanoma survivorship care: a qualitative focus group study

B-Raf specific antibody responses in melanoma patients

Decision-making and autonomy among participants in early-phase cancer immunotherapy trials: a qualitative study

Clinicopathological predictors of recurrence in nodular and superficial spreading cutaneous melanoma: a multivariate analysis of 214 cases

Patient-identified early clinical warning signs of nodular melanoma: a qualitative study

Similar Documents

Patient perspectives on molecular tumor profiling: “Why wouldn’t you?”

Facilitators and barriers to reducing chemotherapy for early-stage breast cancer: a qualitative analysis of interviews with patients and patient advocates

GNAQmutation in a patient with metastatic mucosal melanoma

Adjuvant immunotherapy recommendations for stage III melanoma: physician and nurse interviews

Silvestrol induces early autophagy and apoptosis in human melanoma cells

Oncological healthcare providers’ perspectives on appropriate melanoma survivorship care: a qualitative focus group study

B-Raf specific antibody responses in melanoma patients

Decision-making and autonomy among participants in early-phase cancer immunotherapy trials: a qualitative study

Clinicopathological predictors of recurrence in nodular and superficial spreading cutaneous melanoma: a multivariate analysis of 214 cases

Patient-identified early clinical warning signs of nodular melanoma: a qualitative study